- Dave Holveck To Retire By May 2013
- Board Conducting Search For Next CEO
- Comments on 2012 and 2013 Full Year Financial Guidance
Amicus Therapeutics, Nantkwest and Organovo are among the premarket biotech movers on Tuesday.
Jim Cramer outlines what he thinks this market needs to keep the Trump rally rolling in 2017.